Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Translational Development Acquisition (TDAC) Notes Payables (2023 - 2026)

Translational Development Acquisition's Notes Payables history spans 3 years, with the latest figure at $500000.0 for Q1 2026.

  • On a quarterly basis, Notes Payables changed N/A to $500000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $500000.0, a N/A change, with the full-year FY2025 number at $200000.0, changed N/A from a year prior.
  • Notes Payables came in at $500000.0 for Q1 2026, up from $200000.0 in the prior quarter.
  • The five-year high for Notes Payables was $500000.0 in Q1 2026, with the low at $100000.0 in Q3 2025.
  • Historically, Notes Payables has averaged $286875.0 across 3 years, with a median of $273750.0 in 2023.